Search results
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Author(s):
Mamas A Mamas
,
Farzin Fath-Ordoubadi
Added:
3 years ago
Article
Author(s):
Shao-Liang Chen
,
Imad Sheiban
Added:
3 years ago
Bifurcation lesions account for approximately 20–30% of all percutaneous coronary interventions (PCIs). Coronary bifurcation sites are prone to developing obstructive atherosclerotic disease due to turbulent blood flow and change of shear stress. With the complexity of bifurcation lesions, several classification systems have been advocated in order to extablish percutaneous strategies.1–3 In fact…
View more
Bionert Stent Angiographic Study
Author(s):
Eulogio García Fernandez
,
Didier Carrie
,
Amadeu Betriu
,
et al
Added:
3 years ago
Article
Clinical Impact of Stent Design
Author(s):
Rebecca L Noad
,
Colm Hanratty
,
Simon J Walsh
Added:
3 years ago
Article
Author(s):
Yves S Alimi
Added:
3 years ago
Peripheral arterial disease (PAD) increases in prevalence and incidence with advancing age, and the shifting demographics of an ageing general population is expected to increase the burden of PAD. Thus, there has been an increased focus on how best to manage this burden. If intervention is deemed necessary, surgery remains the gold standard for certain forms of lower-extremity occlusive disease…
View more
Author(s):
Nikhil Pal
,
Jehangir Din
,
Peter O’Kane
Added:
3 years ago
Introduction
The reduction in risk of cardiac death offered by revascularisation in patients with moderate to large amount of stress-induced myocardial ischaemia has driven advancements in percutaneous coronary intervention (PCI) technology over the last four decades.1 However, despite significant progress in the techniques, equipment and pharmacotherapy, target lesion failure remains the…
View more
Author(s):
John Rawlins
,
Jehangir Din
,
Suneel Talwar
,
et al
Added:
3 years ago
A bifurcation lesion within the coronary arterial circulation is defined as a stenosis occurring at, or adjacent to, a significant division of a major epicardial coronary artery.1 Bifurcation lesions account for 1–20% of all percutaneous coronary interventions (PCIs), and treatment remain technically challenging despite advances in PCI techniques and third-generation drug-eluting stent (DES)…
View more
Author(s):
Nikhil Pal
,
Jehangir Din
,
Peter O’Kane
Added:
3 years ago
The reduction in risk of cardiac death offered by revascularisation in patients with moderate to large amount of stress-induced myocardial ischaemia has driven advancements in percutaneous coronary intervention (PCI) technology over the last four decades.1 However, despite significant progress in the techniques, equipment and pharmacotherapy, target lesion failure remains the Achilles heel of a…
View more
Author(s):
Tim A Fischell
Added:
3 years ago
Coronary artery stenting has evolved substantially since the first use of coronary stenting as an adjunct to balloon angioplasty in the early 1990s. The performance (and particularly the deliverability) of coronary stents has improved such that coronary stenting is now the primary mode of revascularisation for percutaneous coronary interventions in more than 95% of cases.
Although stent delivery…
View more
Author(s):
Giulia Magnani
,
Marco Valgimigli
Added:
3 years ago
Dual antiplatelet therapy (DAPT), defined as the use of a P2Y12 receptor inhibitor (clopidogrel, ticagrelor or prasugrel) and aspirin, is required after percutaneous coronary intervention (PCI) with drug-eluting stents (DES).1 Although the use of DES has been shown to reduce the rate of restenosis as compared with bare-metal stents (BMS), there is concern that DES may be associated with a higher…
View more